Study: Stop taking Zepbound causes the lost weight to be detected

A new group of medicine against obsity increases the enthusiasm of millions of patients and actors in the pharmaceutical sector, but what is the result that the patient faces as soon as he stops taking it? According to a study, published on Monday, a large part of the weight a person loses during treatment will detect it as soon as you stop taking the medicine, suggesting that these new molecules may cause one of the forms of addiction in the long run. US vacation for the study, published in Journal of the American Medical Association, using ‘Tepbound’, using a US metaphor to treat obesity that affects about 40% of adults in the country. “Zipond” belongs to a group of medicine, which also includes the following: Wegovy, Mounjaro and Ozempic, which spread wide in the last phase and increase the hope of millions of patients in the world due to its attractive characteristics; It treats type 2 diabetes, helps with weight loss and can be used to treat obesity. This medicine works as a bowel bowel is the ‘GLB1’, whose role is to stimulate insulin secretion and reduce appetite, by attracting a sense of saturation. The lost weight has been restored. The study searched 670 patients at a weekly dose of “Zipond”, which was taken by injection, which led to the loss of 21% of their weight after 36 weeks. The study participants were distributed in two groups; The first continued to take ‘Zibound’, and the second received a false treatment. After 88 weeks (more than a one and a half), those who received imaginary treatment recovered about half the weight they lost, as their weight continued 10% less than when you started taking treatment. The weights of the group that dealt with “Zipond” still dropped; The BMI fell 25% from what it was at the beginning. The group was composed of Argentine, Brazilians, Taiwanese and Americans, while they were 48 years old, and about 70% of them are women. The average weight at the beginning of the study was 107 kg. They all receive tips for less food and exercise. The authors of the study indicated that these results “emphasize the need to continue with the treatment to recover weight and ensure the continued decline,” which has benefits to the heart. Continuous treatment and the study, similar to four other clinical experiments, show that with this new generation medication “the weight is strikingly restored” if the patient stops taking treatment. “Patients, carriers and public permanently understand that obesity is a chronic illness that requires continuous treatment,” Jeff Emic’s laboratories said in a statement. The company “Elay Lily” sells Zipond for $ 1060 in the United States, a high price, and is rarely covered by health insurance companies in the country. The new generation of weight loss medicine increases the risk of problems in the digestive system. Even if these side effects are mostly dangerous, it can be more than the benefits of treatment if taken in the long run.